Back

Temporal changes and treatment-associated stabilization of aortic ruptured plaques assessed by non-obstructive general angioscopy

29 August 2026 (14:15 - 14:45)
Organised by: Logo
Congress Presentation Part of: Targeting inflammation in cardiovascular diseases and pre-clinical models Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Keisuke Kojima

Nihon University School of Medicine, Tokyo (Japan)

3 More presentations in this session

Presentation thumbnail
Inflammation promotes extra-adrenal-ang II–independent aldosterone release by circulating immune cells in patients with coronary artery disease
Doctor A. Mroueh (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
SGLT2 inhibitor dapagliflozin attenuates cardiomyocyte injury and inflammation induced by PI3Kα-selective inhibitor alpelisib and fulvestrant under hyperglycemia
Doctor V. Quagliariello (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Impact of inclisiran on the cardiometabolic–inflammatory index: a real-world observational study
Doctor Q. Zhang (Guangzhou, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Targeting inflammation in cardiovascular diseases and pre-clinical models

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study
29 August 2026
thumbnail
Congress Presentation
Aortic plaque characteristics and hypertension: insights from non-obstructive general angioscopy
29 August 2026
thumbnail
Congress Presentation
Association of apolipoprotein B and lipoprotein(a) with severe atherosclerotic cardiovascular disease in patients with acute coronary syndrome: the modifying effect of prior lipid-lowering therapy.
28 August 2026
thumbnail
Congress Presentation
Systemic atherosclerosis assessment using lipoprotein(a) and angioscopy: a prospective study of cholesterol crystal detection
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources